KRAS and sarcoma: Taken together, immunohistochemical characterization supports an epithelial origin of the tumors generated using the HPV + SONIC system in conjunction with AKT and c-MYC oncogenes consistent with carcinoma, while tumors generated using the Kras + HPV + SONIC system generated sarcoma.